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A B S T R A C T
By selective breeding, two sublines of rats with high or low activity of platelet serotonin (5HT) transporter (5HTt)
have been developed (Wistar-Zagreb 5HT rats). Previous studies demonstrated significant differences between the sub-
lines in the expression of platelet 5HTt at the level of both, mRNA and protein. Pharmacological studies showed marked
alterations in brain 5HTt function, indicating differences in central serotonin homeostasis, although analysis of re-
gional brain 5HTt gene expression did not show analogous differences. In this study, we searched for possible changes in
the expression of the two central 5HT receptor subtypes: 5HT-1A and 5HT-1B, both participating in the regulation of
brain 5HT transmission. Semi-quantitative RT-PCR, with three different housekeeping genes as internal standards,
showed no differences in the levels of 5HT-receptor expression between the sublines. Results suggest that constitutional
alteration of 5HT homeostasis, induced by selective breeding for the extremes of platelet 5HTt activity, did not cause mea-
surable changes in the expression of central 5HT-1A (hippocampus) and 5HT-1B (striatum) receptors in the mentioned
rat sublines under physiological conditions.
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Introduction
Serotonin (5-hydroxytryptamine, 5HT) exerts its ef-
fects through at least 15 different receptors, which are
grouped into 7 main types. All 5HT receptor subtypes,
except for 5HT-3 receptor, are members of the G-protein
coupled receptor superfamily1.
Serotonin-1A (5HT-1A) receptors are the most exten-
sively studied of all 5HT receptor subtypes and have
been shown to have a role in physiological functions such
as cognition and emotions; they also play an important
role in regulation of neuroendocrine functions and re-
sponses to stress2, as well as in neural development3.
They are involved in etiopathology of certain neuropsy-
chiatric disorders, e.g. anxiety and depression4,5, and in
the mechanisms of action of antidepressant drugs6.
5HT-1A receptors are expressed both, postsynapti-
cally to the 5HT neurons (in forebrain regions, particu-
larly in hippocampus) and presynaptically, on soma and
dendrites of the 5HT neurones (in the raphe nuclei re-
gion)7. This heterogeneity in distribution of 5HT-1A re-
ceptors has been associated with diversity in pharmacol-
ogy and signal transduction characteristics of the recep-
tor3,8. By regulation of neuronal firing, somatodendritic
5HT-1A autoreceptors are particularly important in reg-
ulation of serotonergic neurotransmission, as demon-
strated in electrophysiological and microdialysis studi-
es9. Postsynaptic 5HT-1A receptors seem to participate in
modulating release of other neurotransmitters (acetyl-
choline, noradrenaline)7, contributing thus to the overall
transmission10. Mice with genetically inactivated 5HT-
1A receptor (5HT-1A knockout mice) develop anxiety-
like phenotype and increased responsiveness to stress11.
Agonists of 5HT-1A receptors act as psychoactive agents
with both, anxiolytic and antidepressant effects2, and, in
some paradigms, display anti-aggressive effects12.
Serotonin-1B receptors (5HT-1B) have been found on
both, serotonergic and non-serotonergic neurones, act-
ing as presynaptic auto- and hetero-receptors. By regu-
lating terminal serotonin release12, they have an impor-
tant role in controlling synaptic 5HT transmission. They
are involved in several physiological functions, behav-
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iours and diseases, including locomotor activity, drug
abuse, migraine, anxiety states and aggressive beha-
vior12,13. 5HT-1B knockout mice showed increased ag-
gressiveness, increased exploratory activity14 and increa-
sed vulnerability to cocaine15. Similarly to 5HT-1A recep-
tors, expression of 5HT-1B receptors is also influenced by
antidepressant drugs16. Drugs acting as 5HT-1B agonists
reduce aggressive behavior12,13 and have shown efficacy
in the acute treatment of migraine1,13.
By selective breeding for the extreme values of pla-
telet serotonin level (PSL), we have previously developed
two sublines of rats differing markedly in this trait17.
Further studies indicated platelet serotonin transporter
(5HTt) as the protein substrate being under genetic pres-
sure and underlying the observed differences in PSL be-
tween sublines18,19. This allowed more specific selective
breeding for the extreme values of platelet serotonin up-
take (PSU) velocity, which finally resulted in develop-
ment of two rat sublines with high and low 5HTt velocity,
referred to as Wistar-Zagreb 5HT rats. It seems that, be-
sides in platelets, selection process affected serotonin ho-
meostasis in general, including the brain20,21. Indeed,
pharmacological challenge with citalopram (SSRI antide-
pressant) resulted in markedly different response, with
respect to the extracellular 5HT level in ventral hippo-
campi, between 5HT-sublines21. Behavioral studies sho-
wed differences in learning ability, motor functions and
anxiety-like behaviors22,23, and there is evidence that
these sublines differ in alcohol intake and preference24.
Detailed characterisation of high-5HT and low-5HT ani-
mals at the neurochemical and molecular genetic levels
are in course. Although studies on the expression of
neuronal 5HTt gene in brain cortex did not show signifi-
cant differences between the sublines25, the observed be-
havioral/functional differences strongly indicate hyper-
and hypo-serotonergic neurotransmission in brains of
high-5HT and low-5HT subline, respectively, making stu-
dies of possible adaptational changes in neuronal 5HT
receptors warranted.
This study was aimed at the mRNA encoding the two
5HT receptor subtypes, 5HT-1A and 5HT-1B in hippo-
campus and striatum, respective regions of their abun-
dant expression.
Materials and Methods
Studies were performed on sublines of Wistar-Za-
greb 5HT rats, developed as described previously25.
Shortly, at the age of 5–6 weeks, PSL and PSU were de-
termined in offspring of each generation and the males
and females displaying the extreme values of PSU were
mated to start a new generation of the high-5HT and
low-5HT sublines, respectively. In this study females
from the 15th breeding generation, aged about 12
months were used (N = 8 per group). They were housed
three per cage with free access to commercial rat chow
and tap water. All experiments were performed in accor-
dance with the NIH Guide for the Care and Use of Labo-
ratory Animals.
PSL and PSU were measured in samples of platelet-
rich plasma (PRP) obtained from 1 mL of venous blood,
according to reported procedure26,27. Tissue (hippocampi
and striata) were quickly excised from the fresh brains,
after decapitation of the animal, and rapidly frozen in
the liquid nitrogen.
RNA was isolated from brain tissue by standard acid
guanidinium-phenol-chloroform extraction28. Isolated RNA
was further purified with RNeasy micro kit (Qiagen,
Germany), which included removal of genomic DNA. 1
mg of total RNA was used for synthesis of single-stranded
cDNA. Reverse transcription (RT) mixture contained fol-
lowing constituents: 2 mL of oligo d(T)16 primers, 1× RT
buffer, 1 mM deoxynucleotide triphosphate, 5 mM MgCl2,
20 U of RNasIn and 15 U of AMV reverse transcriptase
(Promega, USA).
PCR was performed in a total volume of 20 mL, which
contained 1 mL of RT mixture, 1× PCR buffer, 0.2 mM
dNTP and 0.6 U Taq DNA polymerase (Applied Biosis-
tems, USA). Final concentrations of MgCl2 and specific
oligonucleotide primers, as well as sequences of oligonu-
cleotide primers25,29,30 and expected RT-PCR product si-
zes are given in Table 1. All oligonucleotide primers were
custom synthesized by Life Technologies (Vienna, Aus-
tria). The PCR conditions were as follows: 30’’ at 94 °C,
30’’ at 60 °C and 45’’ at 72 °C. To determine the appropri-
ate number of PCR cycles, at which linear phase is main-
tained, for each primer set PCRs at different number of
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cycles, and with given amount of cDNA (1 mL), were run.
Optimal number of cycles for each set of primers is also
given in Table 1. Three typical housekeeping genes (GA-
PDH, b-actin, cyclophylin B) were used as internal con-
trols. Expression of 5HT-1A receptor gene was studied in
hippocampus, and expression of 5HT-1B receptor gene in
striatum.
10 mL of PCR products were separated on a 1.5%
agarose gel with TAE buffer, containing 0.1% ethidium
bromide. Electrophoresis of PCR products from each re-
action revealed single band of the expected product size
(see Table 1). Gels were scanned on the Image Master
VDS apparatus. Digital images were densitometrically
analysed using Image MasterTM software (Pharmacia
Biotech, USA).
Relative amounts of 5HT-1A and 5HT-1B mRNAs
were expressed as ratios between the amount of PCR
product of each of the 5HT receptor cDNAs and the
amount of the PCR product of each of the control gene
cDNAs. Results are given as meansstandard deviations
(X±SD). Significance of the differences between the
mean values was checked using t-test, with the level of
significance set at 0.05.
Results
By the use of described protocols relative 5HT-1A and
5HT-1B mRNA abundances were compared in brains of
animals from high-5HT and low-5HT sublines of Wistar-
Zagreb 5HT rats. The same groups of animals demon-
strated approximately twofold difference in their platelet
5HT transporter velocity (high-5HT subline: 0.71±0.18
nmol 5HT/mg protein/min; low-5HT subline: 0.38±0.05
nmol 5HT/mg protein/min).
5HT-receptor mRNA from brains of the two high-5HT
and the two low-5HT animals were analysed in the same
experiment simultaneously with the three corresponding
reference genes (GAPDH, b-actin, cyclophylin B), used as
internal standards for normalising 5HT-receptor mes-
sages. Data are given in Table 1.
Figure 1 shows the results of 5HT-1A gene expression
in hippocampi of Wistar-Zagreb 5HT sublines. 5HT re-
ceptor gene/reference gene signal ratios were calculated
for all three referent genes and then the level of 5HT-1A
expression in low-5HT subline is given as a percentage of
the relative 5HT-1A expression in high-5HT subline (des-
ignated as 100%). No difference in the expression of
5HT-1A gene in the hippocampus was observed between
sublines, regardless of the housekeeping gene used to
normalise receptor signal (high-5HT subline: 0.66±0.09,
0.85±0.19, 0.98±0.26; low-5HT subline: 0.74±0.29, 0.88
±0.13, 0.94±0.14; signal intensities relative to the ex-
pression of GAPDH, b-actin, and cyclophylin B, respec-
tively).
Analogous analysis of 5HT-1B gene expression in stri-
ata of high- and low-5HT sublines is shown in Figure 2.
Again, no differences between the sublines were found
(high-5HT subline: 0.44±0.06, 0.62±0.11, 1.22±0.27; low-
5HT subline: 0.42±0.09, 0.62±0.17, 1.23±0.39; signal
intensities relative to the expression of GAPDH, b-actin,
and cyclophylin B, respectively).
Discussion
By using the originally developed method for the ex
vivo monitoring of PSU kinetics in the individual rat27,
the directed genetical selection of animals for the ex-
treme values of PSU resulted in development of two
sublines of »Wistar-Zagreb 5HT rats«31. They demon-
strated pronounced differences in the velocity of platelet
5HTt, which is encoded by the same gene as its central
counterpart. Further neuropharmacological and behav-
ioural studies suggested that the selection process had
functional impact also on the brain serotonergic ho-
meostasis20,21,22,23. Although molecular genetic studies
showed clear differences in platelet 5HTt mRNA and
protein levels between the sublines18,19, studies on the
expression of 5HTt gene in brain cortex did not demon-
strate analogous differences25. Under physiological con-
ditions, the activity of 5HT transporters in brain cortex
also seems to be similar between 5HT-sublines (unpub-
lished results). However, constitutively altered brain
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Fig. 1. 5HT-1A expression in hippocampi of animals from high-
5HT and low-5HT sublines. Relative 5HT-1A mRNA levels are
expressed as ratios with respect to different control genes (GA-
PDH, b-actin and cyclophylin). The level of 5HT-1A expression in
low-5HT subline is given as a percentage of expression in high-
-5HT subline (=100%). Each column represents XSD of 8 ani-
mals. No significant differences were detected.
Fig. 2. 5HT-1B expression in striata of animals from high-5HT
and low-5HT sublines. Relative 5HT-1B mRNA levels are expre-
ssed as ratios with respect to different control genes (GAPDH,
b-actin and cyclophylin). The level of 5HT-1B expression in low-
5HT subline is given as a percentage of expression in high-5HT
subline (=100%). Each column represents XSD of 8 animals.
No significant differences were detected.
functioning, as demonstrated by differences in brain
5HT turnover (unpublished results), in extrasynaptic
5HT concentration21, and in response to pharmacological
challenges21 between the sublines, strongly suggest dif-
ferentially regulated brain 5HT transmission, possibly
involving 5HT receptors.
Thus, this study was aimed to compare the expression
of 5HT-1A and 1B receptors, as important regulators of
5HT nerotransmission12,32, in brains of Wistar-Zagreb
5HT rats. Expression of both receptor genes was studied
in regions where they are abundantly expressed – 5HT-
-1A receptor in hippocampus, and 5HT-1B receptor in
striatum. In order to obtain more reliable results, expres-
sion of target genes was related to three different refer-
ence genes in parallel. We have shown that messages for
both 5HT-receptor genes under study are quite similar
between the sublines, notwithstanding reference gene
used to normalise expression signals.
Expression of 5HT-1A and 5HT-1B receptor genes has
been explored in mice with genetically inactivated 5HTt
gene, demonstrating region-specific changes in the ex-
pression of 5HT-1A and 5HT-1B receptor mRNAs33,34.
Fabre et al. (2001) have shown marked reduction in
5HT-1A mRNA levels in raphe region, in contrast to
higher level of this transcript measured in hippocam-
pus33, with the expression of 5HT-1B receptor gene not
differing between knockout and wild type mice33. Simi-
larly, Li et al. (2000) have found significant decrease of
5HT-1A mRNA level only in dorsal raphe area, while
mRNA levels in hypothalamus remained unchanged
when compared to wild type animals34. Electrophysiolo-
gical studies on 5HTt knockout mice reported regional
differences (raphe vs hippocampus) in pharmacologically
induced 5HT-1A receptor desensitization35. In addition,
chronic treatment of rats with selective 5HT reuptake
inhibitor, fluoxetine, resulted in region-specific adapta-
tion of 5HT-1A and 5HT-1B receptor, at both mRNA36
and protein function level36,37.
All these findings suggest that the adaptational chan-
ges in 5HT-1A and -1B receptors could have been ex-
pected in our animal model. The observed absence of dif-
ferences in their expression between sublines might be
due to several reasons.
First, changes could have occurred only at the recep-
tor protein level, without altering mRNA expression.
Similarly, Fabre et al. (2000) found significant decrease
in 5HT-1B receptor labelling in 5HTt knockout mice,
while levels of 5HT-1B mRNA revealed no differences. In
this case, post-transcriptional steps accounted for the
mentioned down-regulation of 5HT-1B receptors33.
Secondly, a kind of robust alteration in brain neuro-
chemistry, which could be induced by gene knockout,
pharmacological challenge or stressful event, might be
needed to provoke measurable changes in the adaptation
of receptors. Thus, in contrast to our model, 5HTt knock-
out mice showed marked reductions in 5HT concentra-
tions in various brain regions, while levels in heterozy-
gous mice remained unchanged38. Literature data repea-
tedly show influence of stress on the expression of 5HT-
1A receptors39,40,41, at both mRNA and protein level, as
well as on the expression of 5HT-1B receptors42,43.
Finally, the present study was aimed at the postsy-
naptic 5HT receptors, while the literature data reported
notable changes in the presynaptic receptors of the raphe
region.
Our future studies will be aimed to the possible chan-
ges of the expression of 5HT-1A and 5HT-1B autore-
ceptors in raphe nuclei, as well as changes of the protein
abundance/function (i.e. Western blot and/or receptor
binding studies), both in physiological conditions and af-
ter a challenge. Once the nature of the changes in the
central 5HT homeostasis of Wistar-Zagreb 5HT rats is
defined, the sublines might represent a useful model of
animals with constitutionally up- and down-regulated
5HT neurotransmission, and could find applications in
different fields of 5HT-related research.
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EKSPRESIJA GENA ZA 5HT-1A I 5-HT-1B RECEPTORE U MOZGU
WISTAR-ZAGREB 5HT [TAKORA
S A @ E T A K
Usmjerenom selekcijom prema ekstremnim vrijednostima brzine trombocitnog serotoninskog prijenosnika (5HTt)
razvijene su dvije sublinije {takora s visokom odnosno niskom vrijedno{}u toga parametra, nazvane »Wistar-Zagreb
5HT {takori«. Prethodna istra`ivanja pokazala su zna~ajne razlike izme|u sublinija u ekspresiji trombocitnog 5HTt, na
razini i mRNA i proteina. U mozgu sublinija nisu pokazane analogne razlike u ekspresiji gena za 5HTt, iako farma-
kolo{ke studije pokazuju jasne funkcionalne promjene 5HT prijenosnika u ventralnom hipokampusu koje upu}uju na
razli~itu homeostazu centralnog serotonina kod 5HT-sublinija. U ovom radu je istra`ena ekspresija gena za dva podtipa
5HT receptora: 5HT-1A receptor u hipokampusu i 5HT-1B receptor u strijatumu 5HT-sublinija. Metodom semi-kvan-
titativnog RT-PCR, provedenog uz tri razli~ita referentna gena, nisu pokazane razlike u ekspresiji navedenih receptor-
skih gena. Rezultati upu}uju da konstitucijske promjene 5HT homeostaze, nastale kao posljedica selektivnog odabira
`ivotinja prema aktivnosti 5HT prijenosnika, nisu dovele do promjena u ekspresiji postsinapti~kih 5HT-1A, odnosno
5HT-1B receptora kod Wistar-Zagreb 5HT {takora u fiziolo{kim uvjetima.
